Wetherby Asset Management Inc 180 Life Sciences Corp. Transaction History

Wetherby Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $2.53 $24,737 - $77,266	-30,540 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.53 - $3.9 $4,146 - $6,392	1,639 Added 5.67%	30,540 $79,000
Q4 2021 Feb 14, 2022	SELL	$3.27 - $6.38 $1,052 - $2,054	-322 Reduced 1.1%	28,901 $113,000
Q2 2021 Aug 16, 2021	BUY	$6.7 - $11.98 $195,794 - $350,091	29,223 New	29,223 $292,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $73.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wetherby Asset Management Inc with notifications on news.